$ASTH News

BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target

Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50

Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $47

Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $45

Physician Association Of California And Astrana Health Collaborate To Help Independent Primary Care Physicians Remain Independent In Complex Healthcare System

Barclays Maintains Equal-Weight on Astrana Health, Raises Price Target to $37

BTIG Maintains Buy on Astrana Health, Raises Price Target to $50

Needham Maintains Buy on Astrana Health, Raises Price Target to $41

Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript

Astrana Health, Inc. 2026 Q1 - Results - Earnings Call Presentation

Astrana Health (NASDAQ:ASTH) Post-Earnings Slide: Revenue Beat Fails to Offset EPS Miss

Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $3.984B Est

Astrana Health Sees Q2 Sales $965.000M-$1.000B vs $973.326M Est

Astrana Health Q1 EPS $0.29 Misses $0.30 Estimate, Sales $965.100M Beat $949.206M Estimate

Baird Maintains Outperform on Astrana Health, Raises Price Target to $40

Astrana Health: A Delegated Risk Model At A Discount

Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $38

Astrana Health, Inc. (ASTH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Astrana Health shares are trading higher after the company reported better-than-expected Q4 results and issued Q1 and FY sales guidance midpoints above estimates.